TickerFactsScreenerDevelopers

Fulcrum Therapeutics, Inc. (FULC) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2017: -$33.27M2018: -$63.67M2019: $87.15M2020: $95.18M2021: $211.54M2022: $198.94M2023: $235.19M2024: $243.03M2025: $349.00M$349.00M
2017Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$349.00M+43.6%
2024$243.03M+3.3%
2023$235.19M+18.2%
2022$198.94M-6.0%
2021$211.54M+122.2%
2020$95.18M+9.2%
2019$87.15M+236.9%
2018-$63.67M-91.4%
2017-$33.27M—